Can a peptide shield kidneys during bypass surgery? new trial aims to find out
Disease control
Recruiting now
This Phase 2 trial tests whether the drug LSALT peptide can prevent or reduce acute kidney injury in 240 adults undergoing on-pump cardiac surgery. Participants receive either the drug or a placebo before surgery, and doctors monitor kidney function for a week. The goal is to see…
Phase: PHASE2 • Sponsor: Arch Biopartners Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC